308 related articles for article (PubMed ID: 38711936)
1. Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering.
Wang J; Zhang Z; Liang R; Chen W; Li Q; Xu J; Zhao H; Xing D
Mater Today Bio; 2024 Jun; 26():101068. PubMed ID: 38711936
[TBL] [Abstract][Full Text] [Related]
2. Lymph node-targeting nanovaccines for cancer immunotherapy.
Wang Q; Wang Z; Sun X; Jiang Q; Sun B; He Z; Zhang S; Luo C; Sun J
J Control Release; 2022 Nov; 351():102-122. PubMed ID: 36115556
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
4. Nanovaccine-based strategies for lymph node targeted delivery and imaging in tumor immunotherapy.
He A; Li X; Dai Z; Li Q; Zhang Y; Ding M; Wen ZF; Mou Y; Dong H
J Nanobiotechnology; 2023 Jul; 21(1):236. PubMed ID: 37482608
[TBL] [Abstract][Full Text] [Related]
5. Cell and tissue engineering in lymph nodes for cancer immunotherapy.
Najibi AJ; Mooney DJ
Adv Drug Deliv Rev; 2020; 161-162():42-62. PubMed ID: 32750376
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances of Emerging Spleen-Targeting Nanovaccines for Immunotherapy.
He X; Wang J; Tang Y; Chiang ST; Han T; Chen Q; Qian C; Shen X; Li R; Ai X
Adv Healthc Mater; 2023 Sep; 12(23):e2300351. PubMed ID: 37289567
[TBL] [Abstract][Full Text] [Related]
7. Engineering the Deformability of Albumin-Stabilized Emulsions for Lymph-Node Vaccine Delivery.
Song T; Xia Y; Du Y; Chen MW; Qing H; Ma G
Adv Mater; 2021 Jul; 33(26):e2100106. PubMed ID: 34013604
[TBL] [Abstract][Full Text] [Related]
8. Lymph node targeting strategies to improve vaccination efficacy.
Jiang H; Wang Q; Sun X
J Control Release; 2017 Dec; 267():47-56. PubMed ID: 28818619
[TBL] [Abstract][Full Text] [Related]
9. Decellularized Lymph Nodes as Scaffolds for Tissue Engineered Lymph Nodes.
Cuzzone DA; Albano NJ; Aschen SZ; Ghanta S; Mehrara BJ
Lymphat Res Biol; 2015 Sep; 13(3):186-94. PubMed ID: 25144673
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Regeneration of Lymphatic and Immune Cell Functions upon Lympho-organoid Transplantation.
Lenti E; Bianchessi S; Proulx ST; Palano MT; Genovese L; Raccosta L; Spinelli A; Drago D; Andolfo A; Alfano M; Petrova TV; Mukenge S; Russo V; Brendolan A
Stem Cell Reports; 2019 Jun; 12(6):1260-1268. PubMed ID: 31155505
[TBL] [Abstract][Full Text] [Related]
11. Immunological perspectives on spatial and temporal vaccine delivery.
Zhu M
Adv Drug Deliv Rev; 2021 Nov; 178():113966. PubMed ID: 34506868
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology-Based Approaches to Promote Lymph Node Targeted Delivery of Cancer Vaccines.
He R; Zang J; Zhao Y; Dong H; Li Y
ACS Biomater Sci Eng; 2022 Feb; 8(2):406-423. PubMed ID: 35005881
[TBL] [Abstract][Full Text] [Related]
13. Rapid Generation of hPSC-Derived High Endothelial Venule Organoids with In Vivo Ectopic Lymphoid Tissue Capabilities.
Wang X; Li X; Zhao J; Li Y; Shin SR; Ligresti G; Ng AHM; Bromberg JS; Church G; Lemos DR; Abdi R
Adv Mater; 2024 Apr; 36(15):e2308760. PubMed ID: 38306610
[TBL] [Abstract][Full Text] [Related]
14. Application of Nano-Delivery Systems in Lymph Nodes for Tumor Immunotherapy.
Xia Y; Fu S; Ma Q; Liu Y; Zhang N
Nanomicro Lett; 2023 Jun; 15(1):145. PubMed ID: 37269391
[TBL] [Abstract][Full Text] [Related]
15. Nanobiomaterial-based vaccination immunotherapy of cancer.
Chen F; Wang Y; Gao J; Saeed M; Li T; Wang W; Yu H
Biomaterials; 2021 Mar; 270():120709. PubMed ID: 33581608
[TBL] [Abstract][Full Text] [Related]
16. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
17. An Albumin-binding Polypeptide Both Targets Cytotoxic T Lymphocyte Vaccines to Lymph Nodes and Boosts Vaccine Presentation by Dendritic Cells.
Wang P; Zhao P; Dong S; Xu T; He X; Chen M
Theranostics; 2018; 8(1):223-236. PubMed ID: 29290804
[No Abstract] [Full Text] [Related]
18. Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine.
Tozuka M; Oka T; Jounai N; Egawa G; Ishii KJ; Kabashima K; Takeshita F
J Dermatol Sci; 2016 Apr; 82(1):38-45. PubMed ID: 26674124
[TBL] [Abstract][Full Text] [Related]
19. Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions.
Li Y; Li S; Jiang Z; Tan K; Meng Y; Zhang D; Ma X
J Nanobiotechnology; 2023 Jul; 21(1):212. PubMed ID: 37415161
[TBL] [Abstract][Full Text] [Related]
20. In Situ Tumor Vaccine for Lymph Nodes Delivery and Cancer Therapy Based on Small Size Nanoadjuvant.
Zhang H; Zhang Y; Hu H; Yang W; Xia X; Lei L; Lin R; Li J; Li Y; Gao H
Small; 2023 Aug; 19(33):e2301041. PubMed ID: 37078903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
